APO RESEARCH · REPORT
Helicobacter Pylori Testing
This report studies the Helicobacter Pylori Testing market, Helicobacter pylori testing is used to diagnose an infection due to the bacteria and to evaluate the effectiveness of treatment.
Product & engineering
Understand the product.
This report studies the Helicobacter Pylori Testing market, Helicobacter pylori testing is used to diagnose an infection due to the bacteria and to evaluate the effectiveness of treatment.
Selected research
Market Outlook & Growth Opportunities
Global Helicobacter Pylori Testing Market Outlook and Growth Opportunities 2026
Market perspective
This report studies the Helicobacter Pylori Testing market, Helicobacter pylori testing is used to diagnose an infection due to the bacteria and to evaluate the effectiveness of treatment.
Asia-Pacific is the largest region of Helicobacter Pylori Testing, with a market share about 30%, followed by Europe and North America, etc. Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience and Bio-Rad Laboratories are the key manufacturers of industry, and top 10 players had less than 25% combined market share.
This report provides an overview of the global Helicobacter Pylori Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Helicobacter Pylori Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Helicobacter Pylori Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Helicobacter Pylori Testing market.
Helicobacter Pylori Testing Segment by Company
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept
Helicobacter Pylori Testing Segment by Type
With Endoscopy
Without Endoscopy
Helicobacter Pylori Testing Segment by Application
Physical Examination Center
Hospitals
Others
Helicobacter Pylori Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Helicobacter Pylori Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Helicobacter Pylori Testing key companies, revenue, market share, and recent developments.
3. To split the Helicobacter Pylori Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Helicobacter Pylori Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Helicobacter Pylori Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Helicobacter Pylori Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Testing industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Helicobacter Pylori Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Helicobacter Pylori Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- With Endoscopy
- Without Endoscopy
Applications
- Physical Examination Center
- Hospitals
- Others
Companies covered
- Sekisui Diagnostics
- F. Hoffmann-La Roche
- Medline Industries
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Alpha Laboratories
- EKF Diagnostics
- Quidel
- Halyard Health, Inc
- Cardinal Health
- Beckman Coulter Inc
- Agilent Technologies
- Coris BioConcept
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Helicobacter Pylori Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Helicobacter Pylori Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Helicobacter Pylori Testing Market Dynamics
- 2.1 Helicobacter Pylori Testing Industry Trends
- 2.2 Helicobacter Pylori Testing Industry Drivers
- 2.3 Helicobacter Pylori Testing Industry Opportunities and Challenges
- 2.4 Helicobacter Pylori Testing Industry Restraints
3 Helicobacter Pylori Testing Market by Company
- 3.1 Global Helicobacter Pylori Testing Company Revenue Ranking in 2025
- 3.2 Global Helicobacter Pylori Testing Revenue by Company (2021-2026)
- 3.3 Global Helicobacter Pylori Testing Company Ranking (2024-2026)
- 3.4 Global Helicobacter Pylori Testing Company Manufacturing Base and Headquarters
- 3.5 Global Helicobacter Pylori Testing Company Product Type and Application
- 3.6 Global Helicobacter Pylori Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Helicobacter Pylori Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Helicobacter Pylori Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Helicobacter Pylori Testing Market by Type
- 4.1 Helicobacter Pylori Testing Type Introduction
- 4.1.1 With Endoscopy
- 4.1.2 Without Endoscopy
- 4.2 Global Helicobacter Pylori Testing Sales Value by Type
- 4.2.1 Global Helicobacter Pylori Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Helicobacter Pylori Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Helicobacter Pylori Testing Sales Value Share by Type (2021-2032)
5 Helicobacter Pylori Testing Market by Application
- 5.1 Helicobacter Pylori Testing Application Introduction
- 5.1.1 Physical Examination Center
- 5.1.2 Hospitals
- 5.1.3 Others
- 5.2 Global Helicobacter Pylori Testing Sales Value by Application
- 5.2.1 Global Helicobacter Pylori Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Helicobacter Pylori Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Helicobacter Pylori Testing Sales Value Share by Application (2021-2032)
6 Helicobacter Pylori Testing Regional Value Analysis
- 6.1 Global Helicobacter Pylori Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Helicobacter Pylori Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Helicobacter Pylori Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Helicobacter Pylori Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Helicobacter Pylori Testing Sales Value (2021-2032)
- 6.3.2 North America Helicobacter Pylori Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Helicobacter Pylori Testing Sales Value (2021-2032)
- 6.4.2 Europe Helicobacter Pylori Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Helicobacter Pylori Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Helicobacter Pylori Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Helicobacter Pylori Testing Sales Value (2021-2032)
- 6.6.2 South America Helicobacter Pylori Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Helicobacter Pylori Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Helicobacter Pylori Testing Sales Value Share by Country, 2025 VS 2032
7 Helicobacter Pylori Testing Country-level Value Analysis
- 7.1 Global Helicobacter Pylori Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Helicobacter Pylori Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Helicobacter Pylori Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Helicobacter Pylori Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Helicobacter Pylori Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Helicobacter Pylori Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Helicobacter Pylori Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sekisui Diagnostics
- 8.1.1 Sekisui Diagnostics Company Information
- 8.1.2 Sekisui Diagnostics Business Overview
- 8.1.3 Sekisui Diagnostics Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 Sekisui Diagnostics Helicobacter Pylori Testing Product Portfolio
- 8.1.5 Sekisui Diagnostics Recent Developments
- 8.2 F. Hoffmann-La Roche
- 8.2.1 F. Hoffmann-La Roche Company Information
- 8.2.2 F. Hoffmann-La Roche Business Overview
- 8.2.3 F. Hoffmann-La Roche Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 F. Hoffmann-La Roche Helicobacter Pylori Testing Product Portfolio
- 8.2.5 F. Hoffmann-La Roche Recent Developments
- 8.3 Medline Industries
- 8.3.1 Medline Industries Company Information
- 8.3.2 Medline Industries Business Overview
- 8.3.3 Medline Industries Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 Medline Industries Helicobacter Pylori Testing Product Portfolio
- 8.3.5 Medline Industries Recent Developments
- 8.4 Meridian Bioscience
- 8.4.1 Meridian Bioscience Company Information
- 8.4.2 Meridian Bioscience Business Overview
- 8.4.3 Meridian Bioscience Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Meridian Bioscience Helicobacter Pylori Testing Product Portfolio
- 8.4.5 Meridian Bioscience Recent Developments
- 8.5 Bio-Rad Laboratories
- 8.5.1 Bio-Rad Laboratories Company Information
- 8.5.2 Bio-Rad Laboratories Business Overview
- 8.5.3 Bio-Rad Laboratories Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Bio-Rad Laboratories Helicobacter Pylori Testing Product Portfolio
- 8.5.5 Bio-Rad Laboratories Recent Developments
- 8.6 Thermo Fisher Scientific
- 8.6.1 Thermo Fisher Scientific Company Information
- 8.6.2 Thermo Fisher Scientific Business Overview
- 8.6.3 Thermo Fisher Scientific Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Thermo Fisher Scientific Helicobacter Pylori Testing Product Portfolio
- 8.6.5 Thermo Fisher Scientific Recent Developments
- 8.7 Alpha Laboratories
- 8.7.1 Alpha Laboratories Company Information
- 8.7.2 Alpha Laboratories Business Overview
- 8.7.3 Alpha Laboratories Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Alpha Laboratories Helicobacter Pylori Testing Product Portfolio
- 8.7.5 Alpha Laboratories Recent Developments
- 8.8 EKF Diagnostics
- 8.8.1 EKF Diagnostics Company Information
- 8.8.2 EKF Diagnostics Business Overview
- 8.8.3 EKF Diagnostics Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 EKF Diagnostics Helicobacter Pylori Testing Product Portfolio
- 8.8.5 EKF Diagnostics Recent Developments
- 8.9 Quidel
- 8.9.1 Quidel Company Information
- 8.9.2 Quidel Business Overview
- 8.9.3 Quidel Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Quidel Helicobacter Pylori Testing Product Portfolio
- 8.9.5 Quidel Recent Developments
- 8.10 Halyard Health, Inc
- 8.10.1 Halyard Health, Inc Company Information
- 8.10.2 Halyard Health, Inc Business Overview
- 8.10.3 Halyard Health, Inc Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 Halyard Health, Inc Helicobacter Pylori Testing Product Portfolio
- 8.10.5 Halyard Health, Inc Recent Developments
- 8.11 Cardinal Health
- 8.11.1 Cardinal Health Company Information
- 8.11.2 Cardinal Health Business Overview
- 8.11.3 Cardinal Health Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.11.4 Cardinal Health Helicobacter Pylori Testing Product Portfolio
- 8.11.5 Cardinal Health Recent Developments
- 8.12 Beckman Coulter Inc
- 8.12.1 Beckman Coulter Inc Company Information
- 8.12.2 Beckman Coulter Inc Business Overview
- 8.12.3 Beckman Coulter Inc Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.12.4 Beckman Coulter Inc Helicobacter Pylori Testing Product Portfolio
- 8.12.5 Beckman Coulter Inc Recent Developments
- 8.13 Agilent Technologies
- 8.13.1 Agilent Technologies Company Information
- 8.13.2 Agilent Technologies Business Overview
- 8.13.3 Agilent Technologies Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.13.4 Agilent Technologies Helicobacter Pylori Testing Product Portfolio
- 8.13.5 Agilent Technologies Recent Developments
- 8.14 Coris BioConcept
- 8.14.1 Coris BioConcept Company Information
- 8.14.2 Coris BioConcept Business Overview
- 8.14.3 Coris BioConcept Helicobacter Pylori Testing Revenue and Gross Margin (2021-2026)
- 8.14.4 Coris BioConcept Helicobacter Pylori Testing Product Portfolio
- 8.14.5 Coris BioConcept Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst